About: Natural Killer Cell Functions and Subsets After In Vitro Stimulation with IL‐2 and IL‐12, with Special Emphasis on Intracellular IFN‐γ and NK‐Cell Cytotoxicity

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Natural Killer Cell Functions and Subsets After In Vitro Stimulation with IL‐2 and IL‐12, with Special Emphasis on Intracellular IFN‐γ and NK‐Cell Cytotoxicity Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Natural Killer Cell Functions and Subsets After In Vitro Stimulation with IL‐2 and IL‐12, with Special Emphasis on Intracellular IFN‐γ and NK‐Cell Cytotoxicity
Creator	Thiel, Steffen Astrinidou-Vakaloudi, A Diamanti, I Georgakopoulou, E Hans, Reinholdt Hoffmann, Jürgen Jesper, Ralf Xatzidimitriou, D Xytsas, S
source	PMC
abstract	Materials and methods: Isolated cryopreserved human peripheral blood mononuclear cells (PBMCs) were stimulated with IL‐2 and IL‐12. This stimulation has previously been shown to activate NK cells. Cell cytotoxicity was measured by flow cytometry after incubation with k562 cells. This method was compared to the current standard 51Cr release assay. Cells were treated with BFA to accumulate IFN‐γ, stained for surface markers, permeabilized and stained for intracellular IFN‐γ. Flow cytometry was then performed to measure intracellular IFN‐γ production in PBMC, especially in NK cells. Results: We have demonstrated that stimulation with IL‐2 and IL‐12 is effective in increasing the number of IFN‐γ‐positive cells. There is a distinct difference between the CD3‐CD56dim and the CD3‐CD56bright subsets, with a much greater proportion of IFN‐γ‐positive cells in the CD3‐CD56bright subset. The effects of stimulation with IL‐2 and IL‐12 on cytotoxicity will be presented, as will the relation between IFN‐γ production and cytotoxicity. In addition, we will present results of these assays applied to porcine cells. Discussion: In combination, these tests will address NK cell function by combining cytotoxicity with IFN‐γ production in NK cell subsets. The results will demonstrate whether this could serve as a useful tool in describing NK‐cell function, which could be of value in clinical and experimental settings.
has issue date	2008-06-28(xsd:dateTime)
bibo:doi	10.1111/j.0300-9475.2004.01423y.x
has license	no-cc
sha1sum (hex)	06d205dd86381c1bb4528ef22ebaf37adce62e59
schema:url	https://doi.org/10.1111/j.0300-9475.2004.01423y.x
resource representing a document's title	Natural Killer Cell Functions and Subsets After In Vitro Stimulation with IL‐2 and IL‐12, with Special Emphasis on Intracellular IFN‐γ and NK‐Cell Cytotoxicity
has PubMed Central identifier	PMC7169545
schema:publication	Scand J Immunol
resource representing a document's body	covid:06d205dd86381c1bb4528ef22ebaf37adce62e59#body_text
is schema:about of	named entity 'Rheumatoid Arthritis' named entity 'fusion protein' named entity 'CD8' named entity 'antigens' named entity 'infection' named entity 'ErpA' named entity 'lymphocytes' named entity 'MHC class II' named entity 'Sendai virus' named entity 'Sassari' named entity 'BDCA2' named entity 'IgM' named entity 'SP-A' named entity 'minor salivary gland' named entity 'endothelial cells' named entity 'DCs' named entity 'MASP' named entity 'SARS' named entity 'antigens' named entity 'immunoglobulin' named entity 'MHC I molecules' named entity 'microarray' named entity 'tumour necrosis factor' named entity 'allergy' named entity 'pneumococci' named entity 'CD89' named entity 'liver' named entity 'mutation' named entity 'MASP-2' named entity 'IFN' named entity 'supernatants' named entity 'psoriasis' named entity 'endogenous' named entity 'IFN-a' named entity 'IgM' named entity 'Lactobacillus acidophilus' named entity 'Fel d 1' named entity 'lung' named entity 'CD11b' named entity 'IFN-g' named entity 'antigens' named entity 'Stratagene' named entity 'Flanders Interuniversity Institute for Biotechnology' named entity 'complement' named entity 'epitope mapping' named entity 'tumour cells' named entity 'anaesthetized' named entity 'NK cells' named entity 'Natural Killer Cell' named entity 'TNF-a' named entity 'human blood' named entity 'scFv' named entity 'IL-13' named entity 'IL-12' named entity 'IL-10' named entity 'A549' named entity 'protein' named entity 'mast cell degranulation' named entity 'lactobacilli' named entity 'MBL' named entity 'gram-positive' named entity 'anti-inflammatory' named entity 'TNF-a' named entity 'CRP' named entity 'gram-positive bacteria' named entity 'NK cells' named entity 'MBL' named entity 'lactic acid bacteria' named entity 'mode of administration' named entity 'Pasteur Institute' named entity 'Streptococcus' named entity 'IFN' named entity 'DNA vaccination' named entity 'PD-L2' named entity 'saturation dive'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software